Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zangerle

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
International Archives of Allergy and Immunology|January 1, 1994
Correlation of body mass index with urinary neopterin in individuals infected with human immunodeficiency virusR Zangerle, M Sarcletti, H Gallati, et al.
Zeitschrift Fur Hautkrankheiten|July 1, 1990
[AIDS--mucous membrane manifestations]E Pichler, R Zangerle, W Puelacher, et al.
Pharmacological Research|August 5, 2009
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markersK Kurz, T Teerlink, M Sarcletti, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1994
Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activationR Zangerle, M Sarcletti, H Gallati, et al.
Zeitschrift Fur Stomatologie (1984)|December 1, 1989
[Oral manifestations of HIV infection]W Puelacher, R Zangerle, S Kulmer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1988
Single photon emission computed tomography in AIDS dementia complexP Pohl, G Vogl, H Fill, et al.
Lancet (London, England)|December 3, 1994
Differences in heterosexual transmission of HIV-1 and HIV-2J Möst, L Spötl, M Sarcletti, et al.
Mycoses|November 1, 1993
In vitro susceptibility of Candida albicans, Austria 1992F Allerberger, A Fassl, D Niederwieser, et al.
The Clinical Investigator|August 1, 1992
Association between serum-soluble CD8 levels and parameters of immune activation in patients with human immunodeficiency virus infectionG P Tilz, R Zangerle, G Weiss, et al.
Lancet (London, England)|January 11, 1992
Reducing HIV transmission by seronegative bloodR Zangerle, D Schönitzer, D Fuchs, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
International Archives of Allergy and Immunology|January 1, 1994
Correlation of body mass index with urinary neopterin in individuals infected with human immunodeficiency virusR Zangerle, M Sarcletti, H Gallati, et al.
Zeitschrift Fur Hautkrankheiten|July 1, 1990
[AIDS--mucous membrane manifestations]E Pichler, R Zangerle, W Puelacher, et al.
Pharmacological Research|August 5, 2009
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markersK Kurz, T Teerlink, M Sarcletti, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1994
Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activationR Zangerle, M Sarcletti, H Gallati, et al.
Zeitschrift Fur Stomatologie (1984)|December 1, 1989
[Oral manifestations of HIV infection]W Puelacher, R Zangerle, S Kulmer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1988
Single photon emission computed tomography in AIDS dementia complexP Pohl, G Vogl, H Fill, et al.
Lancet (London, England)|December 3, 1994
Differences in heterosexual transmission of HIV-1 and HIV-2J Möst, L Spötl, M Sarcletti, et al.
Mycoses|November 1, 1993
In vitro susceptibility of Candida albicans, Austria 1992F Allerberger, A Fassl, D Niederwieser, et al.
The Clinical Investigator|August 1, 1992
Association between serum-soluble CD8 levels and parameters of immune activation in patients with human immunodeficiency virus infectionG P Tilz, R Zangerle, G Weiss, et al.
Lancet (London, England)|January 11, 1992
Reducing HIV transmission by seronegative bloodR Zangerle, D Schönitzer, D Fuchs, et al.
Pageof 8